summary: The authors reviewed the most recent studies about oral fingolimod, a promising drug for many autoimmune diseases like MS, with an effective immunosuppressant action and relatively few side effects.

authors: Martini S, Peters H, Bohler T, Budde K.

source: Expert Opin Investig Drugs. 2007 Apr;16(4):505-18

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: